Reference
1) Di Biase L, Elayi CS, Fahmy TS, et al. Atrial fibrillation ablation
strategies for paroxysmal patients: randomized comparison between
different techniques. Circ Arrhythm Electrophysiol 2009; 2: 113–119.
2) Takahashi A, Iesaka Y, Takahashi Y, et al. Electrical connections
between pulmonary veins: implication for ostial ablation of pulmonary
veins in patients with paroxysmal atrial fibrillation. Circulation 2002;
105: 2998–3003.
3) Calkins H, Hindricks G, Cappato R,et al. 2017
HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and
surgical ablation of atrial fibrillation. Heart Rhythm 2017; 14:
e275–e444.
4) Verma Atul, Jiang Chen-yang, Betts Timothy R, et al. Approaches to
catheter ablation for persistent atrial fibrillation. N Engl J Med 2015;
372: 1812–1822.
5) Jadidi A, Müller-Edenborn B, Chen J, et al. The Duration of the
Amplified Sinus-P-Wave Identifies Presence of Left Atrial Low Voltage
Substrate and Predicts Outcome After Pulmonary Vein Isolation in
Patients With Persistent Atrial Fibrillation. JACC Clin Electrophysiol
2018; 4: 531-543.
6) Aytemir K, Amasyali B, Kose S, et al. Maximum P-wave duration and
P-wave dispersion predict recurrence of paroxysmal atrial fibrillation
in patients with Wolff-Parkinson-White syndrome after successful
radiofrequency catheter ablation. J Interv Card Electrophysiol 2004; 11:
21–27.
7) Masuda M, Inoue K, Iwakura K, et al. Impact of pulmonary vein
isolation on atrial late potentials: Association with the recurrence of
atrial fibrillation. Europace 2013; 15; 501–507.
8) Masuda M, Fujita M, Iida O, et al. Left atrial low-voltage areas
predict atrial fibrillation recurrence after catheter ablation in
patients with paroxysmal atrial fibrillation. Int J Cardiol 2018; 257:
97–101.
9) Kostin S, Klein G, Szalay Z, Hein S, Bauer EP, Schaper J. Structural
correlate of atrial fibrillation in human patients. Cardiovasc Res 2002;
54: 361–79.
10) Xie Y, Garfinkel A, Camelliti P, Kohl P, Weiss JN, Qu Z. Effects of
fibroblast-myocyte coupling on cardiac conduction and vulnerability to
reentry: A computational study. Heart Rhythm 2009; 6: 1641–1649.
11) McDowell KS, Vadakkumpadan F, Blake R, et al. Mechanistic inquiry
into the role of tissue remodeling in fibrotic lesions in human atrial
fibrillation. Biophys J 2013; 104: 2764–2773.
12) Gray RA, Pertsov AM, Jalife J. Spatial and temporal organization
during cardiac fibrillation. Nature 1998; 392: 75–78.
13) Davidenko JM, Pertsov AV, Salomonsz R, Baxter W, Jalife J.
Stationary and drifting spiral waves of excitation in isolated cardiac
muscle. Nature 1992; 355: 349–51.
14) Lau DH, Linz D, Schotten U, Mahajan R, Sanders P, Kalman JM.
Pathophysiology of paroxysmal and persistent atrial fibrillation:
rotors, foci and fibrosis. Heart Lung Circ 2017; 26: 887–893.
15) Masuda M, Fujita M, Iida O, et al. Influence of underlying substrate
on atrial tachyarrhythmias after pulmonary vein isolation. Heart Rhythm
2016; 13; 870–878.
16) Pashakhanloo F, Herzka DA, Ashikaga H, et al. Myofiber Architecture
of the Human Atria as Revealed by Submillimeter Diffusion Tensor
Imaging. Circ Arrhythm Electrophysiol 2016; 9: e004133.
17) Miyamoto K, Tsuchiya T, Narita S, et al. Bipolar electrogram
amplitudes in the left atrium are related to local conduction velocity
in patients with atrial fibrillation. Europace 2009; 11: 1597–1605.
18) Mahnkopf C, Badger TJ, Burgon NS, et al. Evaluation of the left
atrial substrate in patients with lone atrial fibrillation using
delayed-enhanced MRI: implications for disease progression and response
to catheter ablation. Heart Rhythm 2010; 7: 1475–1481.
19) Masuda M, Asai M, Iida O, et al. Left atrial voltage mapping with a
direction-independent grid catheter: Comparison with a conventional
circular mapping catheter. J Cardiovasc Electrophysiol
2019;30:2834–2840.
20) Masuda M, Asai M, Iida O, et al. Comparison of electrogram waveforms
between a multielectrode mapping catheter and a linear ablation
catheter. Pacing Clin Electrophysiol
2019; 42, 515–520.